Table 1 Comparison between general characteristics of patients with asthma and with COPD
From: Predictors of cardiovascular disease in asthma and chronic obstructive pulmonary disease
| Â | ASTHMA N. 100 | COPD N. 129 | P |
|---|---|---|---|
Age, years | 59 ± 1.1 | 69 ± 0.9 | < 0.0001 |
BMI | 25.6 ± 0.5 | 26.2 ± 0.45 | 0.010 |
Male, n (%) | 22 (22.0) | 78 (60.5) | < 0.0001 |
Smokers | Â | Â | Â |
  current, n (%) | 10 (10) | 72 (55.8) | < 0.0001 |
  past, n (%) | 8 (8) | 42 (32.6) | < 0.0001 |
Atopy,n (%) | 65 (73.1) | 10 (7.7) | < 0.0001 |
Cardiovascular disease, n (%) | 68 (68) | 117 (90.7) | 0.00002 |
  Pressure overload, n (%) | 38 (38.0) | 59 (45.7) | NS |
  Volume overload, n (%) | 30 (30.0) | 58 (45.0) | 0.021 |
  Subgroup IHD, n (%) | 8 (8.0) | 50 (38.8) | < 0.001 |
  Subgroup PH, n (%) | 0 (0.0) | 25 (19.4) | < 0.001 |
VC*, % predicted | 88.9 ± 1.7 | 83.6 ± 1.8 | 0.033 |
FEV1*, % predicted | 78.0 ± 2.0 | 64.6 ± 1.9 | < 0.0001 |
FEV1/VC* % | 65.7 ± 1.3 | 57.1 ± 1.3 | < 0.0001 |
MEF50*, % predicted | 41.8 ± 2.4 | 29.5 ± 2.1 | < 0.0001 |
PaO2 , mmHg | 74.5 ± 1.6 | 71.4 ± 1.0 | NS |
PaCO2 , mmHg | 38.4 ± 0.5 | 39.8 ± 0.5 | NS |
CRP, mg/ml | 3.4 ± 0.4 | 7.6 ± 0.7 | < 0.0001 |
Beta adrenergic therapy, n (%) | 94 (94.9) | 97 (75.2) | 0.0001 |
Corticosteroid therapy, n (%) | 95 (96) | 90 (69.8) | < 0.0001 |
Anticholinergic therapy, n (%) | 22 (22) | 76 (58.9) | <0.0001 |